LCQ LCQ in Specific Patient Populations 1 — Questions and Answers
Question 1: Has the LCQ been validated for use in patients with COPD?
- Yes — validated and widely used in COPD populations (Correct answer)
- No — COPD patients require a different tool
- Only in mild COPD
- Only in COPD patients without cough
Correct answer: Yes — validated and widely used in COPD populations
The LCQ has been validated in COPD populations and is commonly used to assess the cough-specific quality of life burden in these patients alongside disease-specific COPD tools.
Question 2: Can the LCQ be used in patients with asthma-related chronic cough?
- Yes — it has been applied in asthmatic patients with chronic cough (Correct answer)
- No — asthma requires the ACQ instead
- Only in non-allergic asthma
- Only if combined with spirometry
Correct answer: Yes — it has been applied in asthmatic patients with chronic cough
The LCQ is applicable to asthma patients with chronic cough, capturing cough-related quality of life impacts independent of the underlying diagnosis.
Question 3: Is the LCQ validated for pediatric patients?
- No — it was developed and validated for adults (Correct answer)
- Yes — it is the gold standard for children
- Only for adolescents over 16
- Yes, for children over 5 years old
Correct answer: No — it was developed and validated for adults
The LCQ was developed and validated for use in adults; separate pediatric cough quality of life tools exist for children.
Question 4: In patients with idiopathic chronic cough (ICC), what LCQ scores are typically observed?
- Markedly reduced scores indicating significant quality of life impairment (Correct answer)
- Normal scores indistinguishable from healthy controls
- Scores only reduced in the physical domain
- No reliable data exists for ICC patients
Correct answer: Markedly reduced scores indicating significant quality of life impairment
Patients with idiopathic chronic cough typically demonstrate markedly reduced LCQ scores across all three domains, reflecting profound quality of life impairment.
Question 5: How has the LCQ been used in patients with chronic cough secondary to gastroesophageal reflux (GERD)?
- To monitor quality of life changes as reflux treatment is adjusted (Correct answer)
- To diagnose GERD-related cough
- To measure acid reflux frequency
- To replace pH monitoring
Correct answer: To monitor quality of life changes as reflux treatment is adjusted
In GERD-related cough, the LCQ is used as an outcome measure to track quality of life improvement as anti-reflux therapy is optimized.
Question 6: Has the LCQ been used in post-COVID chronic cough research?
- Yes — emerging research has applied LCQ to post-COVID cough patients (Correct answer)
- No — post-COVID cough requires specialized tools
- Only in hospitalized COVID patients
- LCQ is not sensitive enough for post-COVID use
Correct answer: Yes — emerging research has applied LCQ to post-COVID cough patients
Emerging research has applied the LCQ to assess cough-related quality of life in patients with post-COVID syndrome, given its responsiveness to chronic cough of various etiologies.
LCQ LCQ in Specific Patient Populations 1
Has the LCQ been validated for use in patients with COPD?